Insiders / Sblendorio Glenn / Activity

Activity — Sblendorio Glenn

14 moves.

BiggestBiggest buysBiggest sellsHighest impact
InsidersInstitutions
DateActionCompanyValueShares ΔPosition afterImpact
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Common Stock
$2.07M-143K
-100.00%
0
0.00% of shares
low
Feb 19, 2026GrantMLYS
Mineralys Therapeutics Inc
Common Stock
$0+6K
6,200
<0.01% of shares
low
Jun 17, 2026GrantFDMT
4D Molecular Therapeutics, Inc.
Stock Option (Right to Buy)
+50K
50,000
0.07% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-75K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-42K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-30K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-45K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-36K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-19K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-19K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-16K
-100.00%
0
0.00% of shares
low
Apr 27, 2026OtherFOLD
Amicus Therapeutics Inc
Stock Options (right to buy)
-20K
-100.00%
0
0.00% of shares
low
Jan 5, 2026GrantFDMT
4D Molecular Therapeutics, Inc.
Stock Option (Right to Buy)
+45K
45,000
0.07% of shares
low
Feb 19, 2026GrantMLYS
Mineralys Therapeutics Inc
Stock Option
+8K
8,300
<0.01% of shares
low
← PrevPage 1 of 1Next →